Search for Clinical Trial Results
Peritoneal Neoplasms - 29 Studies Found
Status | Study |
Completed |
Study Name: Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer Condition:
|
Completed |
Study Name: Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis Condition:
|
Recruiting |
Study Name: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer Condition:
|
Completed |
Study Name: Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy Condition:
|
Terminated |
Study Name: Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer Condition:
|
Active, not recruiting |
Study Name: Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma Condition: Liposarcoma Date: 2012-11-05 Interventions: Radiation: Radiotherapy Evaluation of the efficacy of the combination with radio-surgery helical tomothe |
Completed |
Study Name: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer Condition:
|
Recruiting |
Study Name: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum Condition:
Interventions: Drug: Nilotinib-adriamycin The nilotinib-adriamycin combination will be given in 4 cycles of 21 days. In |